These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through ...

The US Food and Drug Administration has approved a new oral antibiotic for treatment of uncomplicated urinary tract ...

Urinary tract infections are common, especially, though not exclusively, in women, and the risk generally increases with age.

A YOUNG woman who thought nothing of her urinary tract infection was later told she in fact had cancer and thought she might ...

On Friday, Iterum Therapeutics plc (NASDAQ:ITRM) received FDA approval for its Orlynvah (sulopenem etzadroxil and probenecid) ...

AIIMS geriatrician Dr Prasun Chatterjee on the most common complaints of those above 70 and the screening tests they should ...

The US FDA has approved Iterum Therapeutics' NDA for ORLYNVAH to treat uncomplicated urinary tract infections (uUTIs).

The latest health news highlights major biotech and pharmaceutical updates, including Septerna's market debut, Sanofi's ...

With flu, COVID-19 and respiratory syncytial virus (RSV) circulating this fall and winter, Lee Health wants to remind you to ...

As October draws to a close, it's time to take a look at the regulatory news that made headlines in the month and look ahead to ...

ORLYNVAH™ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company ...

The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections ...